Financhill
Sell
38

GSK Quote, Financials, Valuation and Earnings

Last price:
$36.97
Seasonality move :
3.98%
Day range:
$36.62 - $37.22
52-week range:
$31.72 - $45.93
Dividend yield:
4.27%
P/E ratio:
23.08x
P/S ratio:
1.88x
P/B ratio:
4.35x
Volume:
3.4M
Avg. volume:
4.7M
1-year change:
-12.88%
Market cap:
$74.6B
Revenue:
$40.1B
EPS (TTM):
$1.58

Analysts' Opinion

  • Consensus Rating
    GSK PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $43.42, GSK PLC has an estimated upside of 18.83% from its current price of $36.54.
  • Price Target Downside
    According to analysts, the lowest downside price target is $35.50 representing 2.85% downside risk from its current price of $36.54.

Fair Value

  • According to the consensus of 6 analysts, GSK PLC has 18.83% upside to fair value with a price target of $43.42 per share.

GSK vs. S&P 500

  • Over the past 5 trading days, GSK PLC has overperformed the S&P 500 by 0.82% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • GSK PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • GSK PLC has grown year-over-year revenues for 7 quarters straight. In the most recent quarter GSK PLC reported revenues of $10.4B.

Earnings Growth

  • GSK PLC has grown year-over-year earnings for 1 quarter straight. In the most recent quarter GSK PLC reported earnings per share of $0.26.
Enterprise value:
90.3B
EV / Invested capital:
2.39x
Price / LTM sales:
1.88x
EV / EBIT:
17.15x
EV / Revenue:
2.25x
PEG ratio (5yr expected):
--
EV / Free cash flow:
19.77x
Price / Operating cash flow:
16.53x
Enterprise value / EBITDA:
9.93x
Gross Profit (TTM):
$28.5B
Return On Assets:
4.35%
Net Income Margin (TTM):
8.13%
Return On Equity:
19.22%
Return On Invested Capital:
8.45%
Operating Margin:
8.58%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $36.2B $37.7B $40.1B $10B $10.4B
Gross Profit $24.4B $27.1B $28.5B $7B $7.1B
Operating Income $8.4B $9.1B $5.1B $1.5B $891.1M
EBITDA $10.9B $11.3B $9.1B $1.4B $2B
Diluted EPS $8.69 $2.99 $1.58 $0.21 $0.26
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $27.6B $25.2B $25.1B $23.8B $21.3B
Total Assets $109.6B $106.8B $72.8B $75.2B $74.6B
Current Liabilities $30.2B $31.9B $27.6B $26.8B $27.2B
Total Liabilities $81.3B $78B $60.6B $58.9B $58.2B
Total Equity $28.4B $28.8B $12.2B $16.3B $16.4B
Total Debt $35.5B $31.3B $24.2B $21.4B $21.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $9.2B $8.4B $8.4B $3.9B $2.9B
Cash From Investing -$10.9B -$2B -$1.6B $374.3M -$1.4B
Cash From Financing $1B -$7B -$6B -$4.4B -$986M
Free Cash Flow $6.4B $5.5B $4.6B $3B $1.5B
GSK
Sector
Market Cap
$74.6B
$44.2M
Price % of 52-Week High
79.57%
48.19%
Dividend Yield
4.27%
0%
Shareholder Yield
5.76%
-0.68%
1-Year Price Total Return
-12.88%
-35.43%
Beta (5-Year)
0.654
0.747
Dividend yield:
4.27%
Annualized payout:
$1.56
Payout ratio:
95.78%
Growth streak:
1 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $36.32
200-day SMA
Sell
Level $38.72
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Buy
Level $35.62
Relative Strength Index (RSI14)
Buy
Level 61.70
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -37.1515
50-day SMA
Buy
Level $34.56
MACD (12, 26)
Buy
Level 0.63
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.572)
Sell
CA Score (Annual)
Level (-1.1849)
Buy
Beneish M-Score (Annual)
Level (-2.471)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.894)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Stock Forecast FAQ

In the current month, GSK has received 2 Buy ratings 3 Hold ratings, and 1 Sell ratings. The GSK average analyst price target in the past 3 months is $43.42.

  • Where Will GSK PLC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that GSK PLC share price will rise to $43.42 per share over the next 12 months.

  • What Do Analysts Say About GSK PLC?

    Analysts are divided on their view about GSK PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GSK PLC is a Sell and believe this share price will drop from its current level to $35.50.

  • What Is GSK PLC's Price Target?

    The price target for GSK PLC over the next 1-year time period is forecast to be $43.42 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is GSK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for GSK PLC is a Hold. 3 of 6 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of GSK?

    You can purchase shares of GSK PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GSK PLC shares.

  • What Is The GSK PLC Share Price Today?

    GSK PLC was last trading at $36.97 per share. This represents the most recent stock quote for GSK PLC. Yesterday, GSK PLC closed at $36.54 per share.

  • How To Buy GSK PLC Stock Online?

    In order to purchase GSK PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
17
CE alert for Feb 21

Celanese [CE] is down 4.21% over the past day.

Sell
22
GLBE alert for Feb 20

Global E Online [GLBE] is down 8.41% over the past day.

Buy
72
HIMS alert for Feb 20

Hims & Hers Health [HIMS] is down 3.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock